No Correlations Between the Development of Specific IgA and IgM Antibodies Against Anti-TNF Blocking Agents, Disease Activity and Adverse Side Reactions in Patients with Rheumatoid Arthritis

The use of tumour necrosis factor (TNF) antagonists (infliximab [IFN], etanercept [ETN], adalimumab [ADA]) has changed the course of many rheumatic diseases, including rheumatoid arthritis (RA). However, some questions concerning their safety have emerged since their approval because they can trigge...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Benucci, Maurizio, Saviola, Gianantonio, Meacci, Francesca, Manfredi, Mariangela, Infantino, Maria, Campi, Paolo, Severino, Maurizio, Iorno, Miriam, Sarzi-Puttini, Piercarlo, Atzeni, Fabiola
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Bentham Open 2013
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3793582/
https://ncbi.nlm.nih.gov/pubmed/24115967
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2174/1874312901307010075
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller